South Florida Encology is categorized under Orthopedic Doctors and Physicians in Hollywood, FL and active since 1997.
South Florida Encology was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Frederick Wittlin at the company’s single location by writing to 1150 North 35th Avenue # 330, Hollywood, Florida FL 33021 or by phoning (954) 364-4370. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | South Florida Encology |
Contact Person: | Frederick Wittlin |
Address: | 1150 North 35th Avenue # 330, Hollywood, Florida 33021 |
Phone Number: | (954) 364-4370 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
South Florida Encology was started in 1997 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Frederick Wittlin for inquiries that concern South Florida Encology by calling the company number (954) 364-4370, as your correspondence is most welcome. Additionally, the physical location of the single location of South Florida Encology can be found at the coordinates 26.020507,-80.178981 as well as the street address 1150 North 35th Avenue # 330 in Hollywood, Florida 33021.
For its online presence, you may visit South Florida Encology’s website at and engage with its social media outlets through on Twitter and on Facebook.